A drug used to treat enlarged prostates may have exciting potential for slowing down Parkinson's, according to research published in the Journal of Clinical Investigation. 

Young golfer finds exercise helps him with his symptoms

New research in rats has shown that alpha-synuclein, an abnormal protein normally found in brain cells affected in Parkinson's, can move rapidly from the gut to the brain. These findings support growing evidence that Parkinson’s may start in the gut rather than the brain.

Mark Goodridge will retire as chair in October, and Gary Shaughnessy has been elected as his successor

A brief summary on what the latest Spending Review means for people with Parkinson's and their families and carers

From 30 August it will be easier for people with 'hidden disabilities' to apply for Blue Badges, and in some situations, they will be automatically entitled. Hidden disabilities can include things like anxiety, freezing or symptoms that may put people at risk of serious harm.

Parkinson’s UK partners with 14 health charities and Sport England in a new campaign

We need as many people as possible to complete the 2019 Your life, your services survey, which is about different aspects of life with Parkinson's. 

Researchers have shown that boosting levels of oestrogen in the brains of mice improved symptoms by slowing the build-up of the toxic protein alpha-synuclein. 

The Critical Path for Parkinson's meeting brought together pharmaceutical companies, universities, charities and regulatory bodies to address barriers to new treatments.